Molecular Partners Ag (MOLN) Assets Average (2021 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Assets Average of $56033.7 for Q1 2026, down 100.0% year-on-year from $78.6 billion in Q1 2025, and down 20.14% on a QoQ basis from $70163.8 in Q4 2025.

Molecular Partners Ag (MOLN) Assets Average (2021 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Assets Average for 6 consecutive years, with $56033.7 the latest figure, recorded in Q1 2026.

  • Quarterly Assets Average fell 100.0% year-over-year to $56033.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56033.7 (down 100.0% YoY) and the FY2025 annual result came in at $90.5 million, down 55.27% from the prior year.
  • Assets Average retreated to $56033.7 in Q1 2026 per MOLN's latest filing, from $70163.8 in the prior quarter.
  • Over the last five years, Assets Average for MOLN reached as high as $169.0 billion in Q2 2022 and fell as low as $56033.7 in Q1 2026.
  • A 5-year average of $99.4 billion and a median of $106.4 billion in 2024 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2022 — Assets Average soared 51.56% — and 2026, when it tumbled 100.0%.
  • Year by year, Assets Average stood at $145.7 billion in 2022, then slipped by 15.18% to $123.6 billion in 2023, then decreased by 27.91% to $89.1 billion in 2024, then tumbled by 100.0% to $70163.8 in 2025, then fell by 20.14% to $56033.7 in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $56033.7, $70163.8, and $70174.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - 56,033.71

Historic Data

Download Data
DateValue
Mar 31, 2026 56,033.71
Dec 31, 2025 70,163.77
Sep 30, 2025 70,174.93
Jun 30, 2025 78.47 Bn
Mar 31, 2025 78.56 Bn
Dec 31, 2024 89.09 Bn
Sep 30, 2024 89.09 Bn
Jun 30, 2024 106.42 Bn
Mar 31, 2024 106.43 Bn
Dec 31, 2023 123.58 Bn
Sep 30, 2023 123.60 Bn
Jun 30, 2023 132.32 Bn
Mar 31, 2023 132.33 Bn
Dec 31, 2022 145.70 Bn
Sep 30, 2022 145.72 Bn
Jun 30, 2022 168.99 Bn
Mar 31, 2022 168.93 Bn
Dec 31, 2021 96.14 Bn